High-dose Dexamethasone Combining Thalidomide Versus Dexamethasone Mono-therapy for Management of Newly-diagnosed ITP
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The project was undertaking by Qilu Hospital of Shandong University in China. In order to
report the efficacy and safety of thalidomide combining with high-dose dexamethasone for the
treatment of adults with primary immune thrombocytopenia (ITP), compared to conventional
high-dose dexamethasone mono-therapy.
Phase:
Phase 2
Details
Lead Sponsor:
Shandong University
Collaborators:
Anhui Medical University Shenzhen Second People's Hospital The Affiliated Hospital of the Chinese Academy of Military Medical Sciences The First Affiliated Hospital of Dalian Medical University